Scientist with son who suffers from chronic fatigue syndrome hopes research can help COVID-19 patients
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an illness that has been found in patients who have recovered from the novel coronavirus and other viral infections like SARS. Dr. Davis, a professor of biochemistry and genetics at Stanford University, set up a research group to study ME/CFS ever since his son fell ill with the condition roughly 10 years ago. Although Davis stressed that the use of Abilify for ME/CFS is still experimental, he said his son showed significant improvement after taking the medication. Davis hopes his research can unlock mysteries surrounding the disease and why it’s becoming more and more common in COVID-19 patients. He said there are drugs and treatments that ME/CFS patients can look into to treat individual symptoms related to the illness. The CDC says (https://www.cdc.gov/me-cfs/treatment/index.html) there is no cure or approved treatment for the disease, although some treatments might provide relief for some patients.